BCRX
BioCryst Pharmaceuticals, Inc. (BCRX) Earnings
Review BioCryst Pharmaceuticals, Inc. (BCRX) earnings with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Annual EPS
- 1.21
- Trailing EPS
- -1.50
- Annual revenue
- $874.84M
- Trailing revenue
- $940.61M
- Next earnings date
- 2026-08-05
- Earnings data source
- MarketBeat historical revenue consensus + S&P Global consensus via StockAnalysis + Finnhub earnings
BioCryst Pharmaceuticals, Inc. (BCRX) Earnings research
The BCRX earnings page organizes the available earnings-per-share and revenue context for BioCryst Pharmaceuticals, Inc.. Earnings trends are more informative when actual results are compared with prior periods, market expectations and management guidance.
Quarterly surprises can move a share price, but their long-term importance depends on margins, cash flow and the durability of demand. Continue to the financials and valuation pages for a broader view.